Section 4: Functions and powers of Council
consolidated text (as at 2017, amended since). juris shows the text as it was consolidated; it does not confirm that this is the law in force today.
4. Functions and powers of Council
The functions and powers of the Council shall be to—
(a) consider and grant or refuse applications for a trial licence;
(Para. (a) came into operation on 24 September 2011.)
(b) issue, amend, extend, review, suspend or cancel trial licences;
(Para. (b) came into operation on 24 September 2011.)
(c) examine and approve the qualifications of every investigator;
(Para. (c) came into operation on 24 September 2011.)
(d) exercise control over licensees and on sites by inspection, examination of any reports received and such other means as may be
appropriate;
(Para. (d) came into operation on 24 September 2011.)
[Issue 10] C25A – 6
Revised Laws of Mauritius
(e) consult regularly with, and consider reports and recommendations
from, the Ethics Committee, the Pharmacovigilance Committee
and the Trade and Therapeutics Committee;
(Para. (e) came into operation on 24 September 2011.)
(f) prepare or approve guidelines for the safe and ethical operation
of clinical trials;
(g) provide for the health, welfare, safety and protection of subjects;
(Para. (g) came into operation on 24 September 2011.)
(h) keep the Register;
(Para. (h) came into operation on 24 September 2011.)
(i) keep a record of all published material relating to clinical trials
conducted in accordance with this Act;
(Para. (i) came into operation on 24 September 2011.)
(j) examine and act on any adverse report or complaint received
from a sponsor, an investigator, an officer, the Pharmacovigilance Committee or any other person;
(Para. (j) came into operation on 24 September 2011.)
(k) arrange, where appropriate, for the training or continued training
of investigators;
(Para. (k) came into operation on 24 September 2011.)
continued on page C25A – 7
C25A – 6 (1) [Issue 10]
Revised Laws of Mauritius
(l) appoint officers whose role includes, but is not limited to, verification of compliance with good clinical practice and pharmacovigilance provisions of this Act through inspections;
(Para. (l) came into operation on 24 September 2011.)
(m) perform such other duties, not inconsistent with this Act, as
may be entrusted to it in writing by the Minister.